¿¬¼ö°­ÁÂ
2024 ´ëÇѽɺÎÀüÇÐȸ µ¿°è½ÉÆ÷Áö¾ö : 2024-01-27

2024 ´ëÇѽɺÎÀüÇÐȸ µ¿°è½ÉÆ÷Áö¾ö : 2024-01-27
±³À°ÀÏÀÚ : 2024-01-27
±³À°Àå¼Ò : ½Ã±×´Ï¿¤ ºÎ»ê, 4Ãþ ±×·£µåº¼·ë

±³À°ÁÖÁ¦ : 2024 ´ëÇѽɺÎÀüÇÐȸ µ¿°è½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѽɺÎÀüÇÐȸ

´ã´çÀÚ : ¹èÀ翬
¿¬¶ôó : 02-3275-5335

À̸ÞÀÏ : kshf3@kshf.or.kr

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 5Á¡

Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 6 ½Ã°£ 10ºÐ

¼¼ºÎ¼ö°­·á : 50,000¿ø  

ºñ°í - »çÀüµî·Ï : Àü¹®ÀÇ(30,000¿ø) / ÀüÀÓÀÇ, ÀÓ»ó°­»ç(10,000¿ø) / Àü°øÀÇ, °£È£»ç, Á¦¾à»ç ±× ¿Ü ÀÇ·áÁ¾»çÀÚ ¹«·á - ÇöÀåµî·Ï: Àü¹®ÀÇ(50,000¿ø) / ÀüÀÓÀÇ, ÀÓ»ó°­»ç(20,000¿ø) / Àü°øÀÇ, °£È£»ç, Á¦¾à»ç ±× ¿Ü ÀÇ·áÁ¾»çÀÚ(10,000¿ø)


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 10:10~10:30 QUEST Trial - Is Qiliqiangxin Really Benefit for Patients? À̼±±â(°í·ÁÀÇ´ë)

±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 10:30~10:50 New Hope for HF? New Era of Anti-obesity Drug ÀÌ»ó¾ð(¿ï»êÀÇ´ë)

±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 10:50~11:10 Aldose Reductase Inhibition in Heart Failure ÀÌÂùÁÖ(¿¬¼¼ÀÇ´ë)

Åä·Ð 01¿ù 27ÀÏ ±×·£µåº¼·ë 11:10~11:30 Discussion ±è¹ÌÁ¤ / ¹ÚÁøÁÖ / ¹ÚÈÆÁØ / À§Áø / Àå¼¼¿ë / Á¶ÇöÀç(°¡Å縯ÀÇ´ë / ¼­¿ïÀÇ´ë / °¡Å縯ÀÇ´ë / °¡ÃµÀÇ´ë / °æºÏÀÇ´ë / ¼­¿ïÀÇ´ë)

±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 11:30~12:00 Translational Research in Heart Failure Naoki Mochizuki(NCVC, Japan)

Åä·Ð 01¿ù 27ÀÏ ±×·£µåº¼·ë 12:00~12:10 Discussion ¹ÚÈÆÁØ / ¿ÀÀç¿ø / ÇÑÁø(°¡Å縯ÀÇ´ë / ¿¬¼¼ÀÇ´ë / ÀÎÁ¦ÀÇ´ë)

½Ä»ç 01¿ù 27ÀÏ ±×·£µåº¼·ë 12:10~13:10 Lunch ()

±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 13:10~13:30 Why PH & RV is Important in HF? Á¤¿íÁø(°¡ÃµÀÇ´ë)

±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 13:30~13:50 How to Evaluate PH & RV? ÀÌÁÖÈñ(ÃæºÏÀÇ´ë)

±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 13:50~14:10 Treatment Options for PH & RV À±Á¾Âù(°¡Å縯ÀÇ´ë)

Åä·Ð 01¿ù 27ÀÏ ±×·£µåº¼·ë 14:10~14:30 Discussion ¹Ú»ó¹Î / ¹è´ëȯ / ½Å¼ºÈñ / À念¿ì / ÃÖÀÇ¿µ(À»ÁöÀÇ´ë / ÃæºÏÀÇ´ë / ÀÎÇÏÀÇ´ë / °¡ÃµÀÇ´ë / ¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 14:30~15:00 Cardiomyopathy : Basic-Clinical-Translational Research °­¼®¹Î(¿¬¼¼ÀÇ´ë)

ÈÞ½Ä 01¿ù 27ÀÏ ±×·£µåº¼·ë 15:00~15:20 Break ()

±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 15:20~15:40 Treatment of HCM Á¤¹ÌÇâ(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 15:40~16:00 Fabry Disease: What Needs to Know? ±èÁöÈñ(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 16:00~16:20 Cardiac Amyloidosis Treatment: Now and Next Weapons ¼ÕÁ¤¿ì(¿¬¼¼¿øÁÖÀÇ´ë)

Åä·Ð 01¿ù 27ÀÏ ±×·£µåº¼·ë 16:20~16:40 Discussion ±è´Ù·¡ / ±è¹Ì³ª / ¼­¼®¹Î / Á¶»óÈ£ / ÃÖÁ¤Çö / Ȳ°æ±¹(¼º±Õ°üÀÇ´ë / °í·ÁÀÇ´ë / °¡Å縯ÀÇ´ë / ÇѸ²ÀÇ´ë / ºÎ»êÀÇ´ë / ÃæºÏÀÇ´ë)

±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 16:40~17:00 How to Diagnose and Treat in My View À±¹ÎÀç(¼­¿ïÀÇ´ë)

Åä·Ð 01¿ù 27ÀÏ ±×·£µåº¼·ë 17:00~17:10 Discussion ±è¹Î¼® / ±èÀÀÁÖ / ¹Ú¼º¹Ì / ¼­Áö¿ø / ½ÉÁö¿µ / Á¶µ¿Çõ / ÃÖ°­¿î / ÃÖ¼ºÈÆ(¿ï»êÀÇ´ë / °í·ÁÀÇ´ë / °í·ÁÀÇ´ë / ¿¬¼¼ÀÇ´ë / ¿¬¼¼ÀÇ´ë / °í·ÁÀÇ´ë / ¿µ³²ÀÇ´ë / ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 17:10~17:30 How to Diagnose and Treat in My View ÇÏ°æÀº(°¡ÃµÀÇ´ë)

Åä·Ð 01¿ù 27ÀÏ ±×·£µåº¼·ë 17:30~17:40 Discussion ±è°èÈÆ / ±èÇüÀ± / ¹ÚÀçÇü / ¾çÅÂÀÏ / À̼ö¿ë / Àü°æÇö / ÇöÁØÈ£ / Ȳ¼®Àç(Àü³²ÀÇ´ë / Àü³²ÀÇ´ë / Ãæ³²ÀÇ´ë / °¡ÃµÀÇ´ë / ºÎ»êÀÇ´ë / ±¹¹Î°Ç°­º¸Çè Àϻ꺴¿ø / ¿ï»êÀÇ´ë / °æ»óÀÇ´ë)

 

  • ÃßõÇϱâ
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù.
¡å
ÀÛ¼ºÀÚ   ºñ¹Ð¹øÈ£
 
¿¬¼ö°­Á ÁÖ°£º£½ºÆ®
Á¦¸ñ

[±¤ÁÖ] ´ëÇѽŰæ¿Ü°úÇÐȸ Á¦42Â÷ Ãá°èÇмú´ëȸ_2nd day : 2024-04-26

±³À°ÀÏÀÚ : 2024-04-26 ±³À°Àå¼Ò : ±¤ÁÖ ±è´ëÁß ÄÁº¥¼Ç ¼¾ÅÍ ÄÁº£¼Ç Ȧ ¿Ü 8°÷ ±³À°ÁÖÁ¦ : ´ëÇѽŰæ¿Ü°úÇÐȸ Á¦42Â÷ Ãá°èÇмú´ëȸ_2nd dayÁÖÃÖ±â°ü : ´ëÇѽŰæ¿Ü°ú

Ãßõ¼ö : 0 , Á¶È¸¼ö : 5,211 , ´ñ±Û¼ö : 0

[¼­¿ï] ½ÉÀå´ë»çÁõÈıºÇÐȸ 2024 7th APCMS (Asia-Pacific CardioMetabolic Syndrome) CONGRESS (1ÀÏÂ÷) : 2024-04..

±³À°ÀÏÀÚ : 2024-04-26 ±³À°Àå¼Ò : Conrad Hotel Seoul (5F PARK BALLROOM) ±³À°ÁÖÁ¦ : 2024 7th APCMS (Asia-Pacific

Ãßõ¼ö : 0 , Á¶È¸¼ö : 5,597 , ´ñ±Û¼ö : 0

[¼­¿ï] 2024 ½ÉÀå»öÀü¿¬±¸È¸ ½ÉÆ÷Áö¿ò : 2024-03-30

±³À°ÀÏÀÚ : 2024-03-30 ±³À°Àå¼Ò : »ï¼º¼­¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ ±³À°ÁÖÁ¦ : 2024 ½ÉÀå»öÀü¿¬±¸È¸ ½ÉÆ÷Áö¿òÁÖÃÖ±â°ü : ´ëÇѳúÁ¹ÁßÇÐȸ ½ÃÇà±â°ü(ÁöºÎ/

Ãßõ¼ö : 0 , Á¶È¸¼ö : 5,476 , ´ñ±Û¼ö : 0

[¼­¿ï] (¿Â¶óÀÎ)Á¦27Â÷ ´ç´¢º´ ±³À°ÀÚ ¿¬¼ö°­Á : 2024-03-30

±³À°ÀÏÀÚ : 2024-03-30 ±³À°Àå¼Ò : ¿Â¶óÀÎ »ýÁß°è ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ)Á¦27Â÷ ´ç´¢º´ ±³À°ÀÚ ¿¬¼ö°­ÁÂÁÖÃÖ±â°ü : ´ëÇÑ´ç´¢º´ÇÐȸ ´ã´çÀÚ : °û¼ÖÀÌ ¿¬¶ôó : 02-71

Ãßõ¼ö : 0 , Á¶È¸¼ö : 5,607 , ´ñ±Û¼ö : 0

[¼­¿ï] (¿Â¶óÀÎ) 2024³â Á¦5ȸ ½Å¼ººóÇ÷¿¬±¸È¸ ¿¬¼ö°­Á : 2024-03-09

±³À°ÀÏÀÚ : 2024-03-09 ±³À°Àå¼Ò : (¿Â¶óÀÎ) ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2024³â Á¦5ȸ ½Å¼ººóÇ÷¿¬±¸È¸ ¿¬¼ö°­ÁÂÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ ½ÃÇà±â°ü(ÁöºÎ/°ú) : ½Å¼ººóÇ÷¿¬

Ãßõ¼ö : 0 , Á¶È¸¼ö : 5,453 , ´ñ±Û¼ö : 0